These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7586950)

  • 21. Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans.
    Dupont I; Berthou F; Bodenez P; Bardou L; Guirriec C; Stephan N; Dreano Y; Lucas D
    Drug Metab Dispos; 1999 Mar; 27(3):322-6. PubMed ID: 10064561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.
    Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical enflurane metabolism by cytochrome P450 2E1.
    Kharasch ED; Thummel KE; Mautz D; Bosse S
    Clin Pharmacol Ther; 1994 Apr; 55(4):434-40. PubMed ID: 8162670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
    Irshaid Y; Adedoyin A; Lotze M; Branch RA
    Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.
    Gill HJ; Tingle MD; Park BK
    Br J Clin Pharmacol; 1995 Dec; 40(6):531-8. PubMed ID: 8703658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pregnenolone 16alpha-carbonitrile on the pharmacokinetics and metabolism of dapsone in rats.
    Lu M; Poloyac SM; McNamara PJ; Blouin RA
    J Pharm Pharmacol; 1999 Jul; 51(7):803-10. PubMed ID: 10467955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
    Ganesan S; Sahu R; Walker LA; Tekwani BL
    J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
    Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis.
    Kharasch ED; Hankins D; Mautz D; Thummel KE
    Lancet; 1996 May; 347(9012):1367-71. PubMed ID: 8637342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-hydroxylation of 4,4'-diaminodiphenylsulphone in liver microsomes and in vivo.
    Tabarelli S; Uehleke H
    Xenobiotica; 1971; 1(4):501-2. PubMed ID: 4152967
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation.
    Kharasch ED; Armstrong AS; Gunn K; Artru A; Cox K; Karol MD
    Anesthesiology; 1995 Jun; 82(6):1379-88. PubMed ID: 7793652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory toxicity of diethyldithiocarbamate (DDTC) and disulfiram and the protective effect of DDTC against the olfactory toxicity of dichlobenil.
    Deamer NJ; Genter MB
    Chem Biol Interact; 1995 Apr; 95(3):215-26. PubMed ID: 7728893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats.
    Brady JF; Xiao F; Wang MH; Li Y; Ning SM; Gapac JM; Yang CS
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):366-73. PubMed ID: 1850173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors.
    Gass RJ; Gal J; Fogle PW; Detmar-Hanna D; Gerber JG
    Eur J Clin Pharmacol; 1998; 54(9-10):741-7. PubMed ID: 9923578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites.
    Israili ZH; Cucinell SA; Vaught J; Davis E; Lesser JM; Dayton PG
    J Pharmacol Exp Ther; 1973 Oct; 187(1):138-51. PubMed ID: 4583459
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.